Product NDC: | 65597-116 |
Proprietary Name: | Tribenzor |
Non Proprietary Name: | olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide |
Active Ingredient(s): | 5; 25; 40 mg/1; mg/1; mg/1 & nbsp; olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 65597-116 |
Labeler Name: | Daiichi Sankyo, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA200175 |
Marketing Category: | NDA |
Start Marketing Date: | 20100731 |
Package NDC: | 65597-116-30 |
Package Description: | 30 TABLET, FILM COATED in 1 BOTTLE (65597-116-30) |
NDC Code | 65597-116-30 |
Proprietary Name | Tribenzor |
Package Description | 30 TABLET, FILM COATED in 1 BOTTLE (65597-116-30) |
Product NDC | 65597-116 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20100731 |
Marketing Category Name | NDA |
Labeler Name | Daiichi Sankyo, Inc. |
Substance Name | AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL |
Strength Number | 5; 25; 40 |
Strength Unit | mg/1; mg/1; mg/1 |
Pharmaceutical Classes | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |